Akech, J., Wixted, J. J., Bedard, K., van der Deen, M., Hussain, S., Guise, T. A., . . . Lian, J. B. (2010). Runx2 association with progression of prostate cancer in patients: Mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene, 29(6), 811. https://doi.org/10.1038/onc.2009.389
Chicago Style (17th ed.) CitationAkech, J., et al. "Runx2 Association with Progression of Prostate Cancer in Patients: Mechanisms Mediating Bone Osteolysis and Osteoblastic Metastatic Lesions." Oncogene 29, no. 6 (2010): 811. https://doi.org/10.1038/onc.2009.389.
MLA (9th ed.) CitationAkech, J., et al. "Runx2 Association with Progression of Prostate Cancer in Patients: Mechanisms Mediating Bone Osteolysis and Osteoblastic Metastatic Lesions." Oncogene, vol. 29, no. 6, 2010, p. 811, https://doi.org/10.1038/onc.2009.389.